Tudor Investment Corp
BEAM icon

Tudor Investment Corp’s Beam Therapeutics BEAM Stock Holding History

Tudor Investment Corp’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13M Buy
47,310
+31,103
+192% +$863K ﹤0.01% 2277
2025
Q4 		$449K Buy
+16,207
New +$413K ﹤0.01% 2778
2025
Q3 		– Sell
-46,378
Closed -$923K – 3363
2025
Q2 		$789K Buy
+46,378
New +$808K ﹤0.01% 2291
2025
Q1 		– Sell
-16,575
Closed -$411K – 3054
2024
Q4 		$411K Sell
16,575
-16,242
-49% -$415K ﹤0.01% 2371
2024
Q3 		$804K Sell
32,817
-16,205
-33% -$419K ﹤0.01% 1757
2024
Q2 		$1.15M Buy
49,022
+1,177
+2% +$28.9K 0.01% 1386
2024
Q1 		$1.58M Buy
+47,845
New +$1.49M 0.01% 1132
2023
Q3 		– Sell
-6,821
Closed -$218K – 2292
2023
Q2 		$218K Buy
+6,821
New +$221K ﹤0.01% 2182
2022
Q4 		– Sell
-40,839
Closed -$1.95M – 2384
2022
Q3 		$1.95M Buy
+40,839
New +$2.33M 0.04% 551
2022
Q2 		– Sell
-7,518
Closed -$431K – 2104
2022
Q1 		$431K Buy
+7,518
New +$493K 0.01% 1358
2021
Q4 		– Sell
-46,974
Closed -$4.09M – 2398
2021
Q3 		$4.09M Buy
46,974
+41,728
+795% +$4.19M 0.07% 346
2021
Q2 		$675K Buy
+5,246
New +$418K 0.01% 1045

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Tudor Investment Corp's BEAM Position: Q1 2026 in Review

Tudor Investment Corp increased its Beam Therapeutics (BEAM) stake by 192% in Q1 2026, buying an estimated $863K and bringing the position to 47,310 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

Tudor Investment Corp first reported a position in BEAM in Q2 2021 and has held it in 12 quarters since. The position peaked at $4.09M in Q3 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Tudor Investment Corp held 47,310 shares of Beam Therapeutics worth $1.13M as of Q1 2026.
  • Tudor Investment Corp bought 31,103 Beam Therapeutics shares in Q1 2026, an estimated $863K.
  • Beam Therapeutics made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2277 holding.
  • Tudor Investment Corp first reported a position in Beam Therapeutics in Q2 2021 and has held it in 12 quarters since.
  • Tudor Investment Corp's Beam Therapeutics position peaked at $4.09M in Q3 2021.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.